Post-earnings recap
Reported
Mon, Jul 27, 2026
EPS actual
$5.98
EPS est.
$5.66
EPS surprise
+5.62%
1-day move
+2.29%
The earnings report shows that Universal Health Services, Inc. exceeded expectations on EPS, which likely contributed to the stock's positive reaction, rising 2.29%. However, without revenue figures or management commentary, investors may have limited insight into the company's overall performance and future outlook. The lack of guidance also leaves uncertainty about upcoming quarters.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $5.98 | N/A | +5.62% |
| Revenue | N/A | N/A | N/A |
No transcript is on record for the earnings call, so the analysis is based solely on numerical results.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±11.2%
Universal Health Services, Inc. (UHS) operates healthcare facilities, including hospitals and outpatient centers, providing essential medical services. As a key player in the health care sector, UHS is influenced by trends such as patient demand, regulatory changes, and advancements in medical technology.
Last quarter
In Q1-2026, UHS reported an EPS of $5.62, exceeding expectations by 6.18%. The stock reacted positively, gaining 2.96% the following day.
Management promises and guidance
EPS beat streak
2Q
EPS beat rate
88%
Avg EPS surprise
+21.46%
Avg 1-day reaction
-0.16%
Investors are cautiously optimistic about UHS's upcoming earnings, given its strong EPS performance in recent quarters. However, uncertainties around revenue growth and patient volume persist.
Bull case
If UHS can demonstrate strong revenue growth and maintain high patient volumes, it could lead to further stock appreciation and investor confidence.
Bear case
Conversely, any signs of declining patient volumes or revenue stagnation could raise concerns about the company's growth trajectory and negatively impact the stock.
Key metrics to watch
EPS
Expected EPS of $5.62Earnings per share (EPS) is a crucial indicator of profitability and will show how well the company is managing costs and generating income.
Revenue Growth
N/ARevenue growth reflects the company's ability to attract and retain patients, which is vital for long-term sustainability.
The print will turn on these.
Q1
What is the expected patient volume growth for the upcoming quarter?
Patient volume is critical for revenue generation, and any decline could signal broader issues in demand for healthcare services.
Q2
How is UHS managing operational costs in the current economic environment?
Cost management will be crucial for maintaining profitability, especially if revenue growth is slower than expected.
Why consensus could be wrong
The Street may be underestimating UHS's ability to leverage outpatient services for growth, which could offset any concerns about inpatient volumes.
Supporting evidence
Recent trends show increased demand for outpatient services, which UHS is well-positioned to capitalize on.
The company's historical performance indicates a strong ability to exceed EPS expectations, suggesting resilience.
Options pricing reflects high volatility, indicating that the market may be overly cautious about potential downside risks.
Key risk
If patient volume growth exceeds 5%, it could significantly alter the market's perception of UHS's growth potential.
Pre-commit to what would confirm each case.
The core debate this quarter revolves around UHS's ability to sustain growth in a challenging healthcare environment.
Bull confirmed if
Demonstrating patient volume growth of at least 5% year-over-year would confirm the bull case.
Bear confirmed if
A decline in patient volume or revenue growth below expectations would support the bear case.
What the market is pricing for the move.
Implied Move
±18.56%
Historical Avg
±2.1%
The options market is pricing in a significant potential move, suggesting that investors expect volatility around the earnings announcement.
Options are pricing ±18.6% while UHS has averaged ±2.1% over the last 8 prints — setup is pricing rich.
ATM IV
0.4%
30d HV
38.4%
Smart-money positioning from the most recent 13F filings.
Institutional
103.40%
of float
Insider
4.98%
of float
Holders
835
institutions
Top Holders· as of Jun 2026
First Eagle Investment Management, LLC
4,554,670 sh · $795.3M
8.81%
2.9%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If UHS beats expectations, history suggests a potential stock increase of around 1.89%, confirming strong operational performance.
In line / cautious
An in-line result could lead to a muted reaction as investors weigh management's commentary on future growth prospects.
Miss
A miss could trigger a decline, with history indicating an average drop of 0.33% when expectations are not met.
The lines on the call that would change the story.
Patient Volume
N/AAn increase in patient volume can indicate stronger demand for services, which is essential for revenue generation.
Blackrock Inc.
4,059,826 sh · $708.9M
7.85%
-6.6%
Vanguard Capital Management LLC
3,392,199 sh · $592.3M
6.56%
-1.8%
Vanguard Portfolio Management LLC
2,452,177 sh · $428.2M
4.74%
-2.2%
Dimensional Fund Advisors LP
2,210,595 sh · $386.0M
4.28%
24.1%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.